ONO-7119-01:Phase I study of ONO-7119 alone and in combination with ONO-4538 in patients with solid tumors

JRCT ID: jRCT2031210373

Registered date:12/10/2021

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: advanced or recurrent solid tumor
• Date of first enrollment: 04/11/2021
• Target sample size: 74
• Study type: Interventional
• Intervention(s): ONO-7119 is administered as a single agent or combination with ONO-4538.

Outcome(s)

• Primary Outcome: Safety and tolerability

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1.Patient with advanced or recurrent solid tumor
2.Patients have an ECOG performance status of 0 to 1
3.Patients with a life expectancy of at least 3 months

Exclude criteria

1.Patients are unable to swallow oral medications
2.Patients with severe complication

Related Information

• Primary Sponsor: Hirashima Yoshinori